Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Leveraging AI to supercharge early commercialisation strategy

How integrating AI across the commercialisation process can drive better outcomes

- PMLiVE

Vertex Pharmaceuticals’ cystic fibrosis therapy Alyftrek granted EC approval

The rare inherited disease affects more than 109,000 people worldwide

Biogen Idec building

Biogen initiates phase 3 study of felzartamab in kidney disease patients

Approximately 36,000 people in the US are affected by primary membranous nephropathy

- PMLiVE

Sepsis and the impact of antibiotic resistance

A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of sepsis on patients, HCPs and health systems

EU flag

EC approves Jazz Pharmaceuticals’ Ziihera for advanced biliary tract cancer

Approximately 26% of biliary tract cancer patients globally have HER2-positive disease

- PMLiVE

Moderna shares positive phase 3 results for mRNA flu vaccine candidate

More than 600,000 people in the US were hospitalised due to flu-related illness last year

- PMLiVE

Cameras on…

Some of the arguments for and against having cameras on in a virtual meeting

MAPS EMEA attendees participating in a round table session

Real-world implementation of AI in medical affairs: Vision, value and collaboration

By Steve Wilson

Amiculum

regeneron headquarters

Regeneron’s Lynozyfic granted FDA accelerated approval to treat multiple myeloma

More than 36,000 new cases of the blood cancer are expected to be diagnosed in the US this year

- PMLiVE

The Considered appoints Tina Bertolini as chief client services officer

Bertolini most recently served as the agency’s head of client services and operations

- PMLiVE

Alzheimer’s disease – the silent pandemic and the positive impact of AI

Using AI, future eye exams could be used to detect early signs of Alzheimer’s and heart disease

Mother playing with son

Using patient personas to add a personal touch to clinical trial recruitment and retention

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links